{
    "eid": "2-s2.0-85069628312",
    "title": "Programmed Cell Death 1 and Programmed Cell Death Ligands in Extranodal Natural Killer/T Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Extranodal NK/T cell lymphoma",
        "Immune checkpoint",
        "Programmed cell death"
    ],
    "authors": [
        "Hamidah Muhamad",
        "Narittee Suksawai",
        "Thamatorn Assanasen",
        "Chantana Polprasert",
        "Udomsak Bunworasate",
        "Kitsada Wudhikarn"
    ],
    "citedby-count": 20,
    "ref-count": 34,
    "ref-list": [
        "CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition",
        "Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways",
        "PD-1 and its ligands in tolerance and immunity",
        "PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies",
        "Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: A summary of immunohistochemical studies",
        "PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome",
        "PD-L1 is upregulated by EBV-driven LMP1 through NF-\u03baB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma",
        "Epstein-Barr virus-associated natural killer/T-cell lymphomas",
        "Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma",
        "Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma",
        "Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type",
        "Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma",
        "Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis",
        "Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: A potential rationale for immunotherapy",
        "Non-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand",
        "Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes",
        "Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: An evidence of predominant role in its downregulation",
        "Genetic and Epigenetic Regulation of PD-1 Expression",
        "Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma",
        "The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma",
        "Predictive Performance of Four Programmed Cell Death Ligand 1 Assay Systems on Nivolumab Response in Previously Treated Patients with Non-Small Cell Lung Cancer",
        "Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer",
        "Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms",
        "Assessment of Concordance between 22C3 and SP142 Immunohistochemistry Assays regarding PD-L1 Expression in Non-Small Cell Lung Cancer",
        "Clinical applications of PD-L1 bioassays for cancer immunotherapy",
        "Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch",
        "Biomarkers of response to PD-1/PD-L1 inhibition",
        "Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response",
        "Soluble PD-1 and PD-L1: Predictive and prognostic significance in cancer",
        "Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: A replication study and combined analysis of 508 patients",
        "High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients",
        "PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase",
        "Successful treatment with anti-programmed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: A case report",
        "Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Ratchadapisek Sompoch Foundation",
        "Thailand Research Fund"
    ]
}